Catalent to go disposable in new plant

Catalent sees a switch from stainless steel to single-use technology for bioprocessing components in its future, with a planned move next year to a new facility in Madison, WI. The move is intended to fortify the company's credentials as a biologic contract development and manufacturing organization. Announcement

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.